Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy

Milan Grkovski, Sally-Ann Emmas and Sean D. Carlin
Journal of Nuclear Medicine October 2017, 58 (10) 1567-1573; DOI: https://doi.org/10.2967/jnumed.117.190892
Milan Grkovski
1Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally-Ann Emmas
2Imaging Team, Personalised Healthcare and Biomarkers, AstraZeneca, Macclesfield, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean D. Carlin
3Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 10 1567-1573
DOI 
https://doi.org/10.2967/jnumed.117.190892
PubMed 
28360207

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 30, 2017
  • Accepted for publication March 16, 2017
  • Published online October 2, 2017.

Article Versions

  • previous version (March 30, 2017 - 05:29).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Milan Grkovski1,
  2. Sally-Ann Emmas2 and
  3. Sean D. Carlin3
  1. 1Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
  2. 2Imaging Team, Personalised Healthcare and Biomarkers, AstraZeneca, Macclesfield, United Kingdom; and
  3. 3Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  1. For correspondence or reprints contact: Sean D. Carlin, John Morgan Building, Room 168C, 3620 Hamilton Walk, University of Pennsylvania, Philadelphia, PA 19104. E-mail: carlins{at}mail.med.upenn.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 12 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51
    Alanna R. Kaplan, Susan E. Gueble, Yanfeng Liu, Sebastian Oeck, Hoon Kim, Zhong Yun, Peter M. Glazer
    Science Translational Medicine 2019 11 492
  • Impact of hypoxia on DNA repair and genome integrity
    Alanna R Kaplan, Peter M Glazer
    Mutagenesis 2020 35 1
  • Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic 18F-FMISO PET for Head and Neck Cancer Radiotherapy
    Daniela Thorwarth, Stefan Welz, David Mönnich, Christina Pfannenberg, Konstantin Nikolaou, Matthias Reimold, Christian La Fougère, Gerald Reischl, Paul-Stefan Mauz, Frank Paulsen, Markus Alber, Claus Belka, Daniel Zips
    Journal of Nuclear Medicine 2019 60 12
  • Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer
    Milan Grkovski, Nancy Y. Lee, Heiko Schöder, Sean D. Carlin, Bradley J. Beattie, Nadeem Riaz, Jonathan E. Leeman, Joseph A. O’Donoghue, John L. Humm
    European Journal of Nuclear Medicine and Molecular Imaging 2017 44 10
  • The Roles of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
    Kenji Hirata, Shigeru Yamaguchi, Tohru Shiga, Yuji Kuge, Nagara Tamaki
    Journal of Clinical Medicine 2019 8 8
  • PARP inhibitor combinations in prostate cancer
    Carmel Pezaro
    Therapeutic Advances in Medical Oncology 2020 12
  • Alanna R. Kaplan, Peter M. Glazer
    2020 354
  • Influence of the scan time point when assessing hypoxia in 18F-fluoromisonidazole PET: 2 vs. 4 h
    Kentaro Kobayashi, Osamu Manabe, Kenji Hirata, Shigeru Yamaguchi, Hiroyuki Kobayashi, Shunsuke Terasaka, Takuya Toyonaga, Sho Furuya, Keiichi Magota, Yuji Kuge, Kohsuke Kudo, Tohru Shiga, Nagara Tamaki
    European Journal of Nuclear Medicine and Molecular Imaging 2020 47 8
  • Glioblastoma PET/MRI: kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer
    Marcel Lindemann, Ana Oteiza, Montserrat Martin-Armas, Yngve Guttormsen, Angel Moldes-Anaya, Rodrigo Berzaghi, Trond Velde Bogsrud, Tore Bach-Gansmo, Rune Sundset, Mathias Kranz
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 4
  • Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models
    Simon Boeke, René M. Winter, Sara Leibfarth, Marcel A. Krueger, Gregory Bowden, Jonathan Cotton, Bernd J. Pichler, Daniel Zips, Daniela Thorwarth
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 10

Article usage

Article usage: March 2017 to April 2025

AbstractFullPdf
Mar 201798016
Apr 2017298043
May 2017136019
Jun 201767024
Jul 201760014
Aug 201760121
Sep 201770011
Oct 201711062070
Nov 2017230933
Dec 201791612
Jan 2018102618
Feb 201850711
Mar 201845610
Apr 20185017
May 201834517
Jun 201835411
Jul 20182719
Aug 20182335
Sep 201828314
Oct 201821516
Nov 201817114
Dec 20181644
Jan 20191432
Feb 201935176
Mar 20192579
Apr 20192017
May 20193628
Jun 2019456
Jul 20191335
Aug 20191056
Sep 20191459
Oct 201915610
Nov 20191229
Dec 20191103
Jan 20201816
Feb 2020322
Mar 202015512
Apr 2020835
May 20209414
Jun 20201146
Jul 202014116
Aug 2020435
Sep 2020938
Oct 202017612
Nov 20201115
Dec 2020649
Jan 202171422
Feb 2021769
Mar 2021134211
Apr 20214205
May 20214173
Jun 2021795
Jul 20214814
Aug 202141217
Sep 20217145
Oct 20211018126
Nov 20215917
Dec 202171714
Jan 20223113
Feb 2022696
Mar 202221012
Apr 202232222
May 202212957
Jun 202221326
Jul 20223205
Aug 20221118
Sep 202221216
Oct 2022499
Nov 2022678
Dec 2022551
Jan 202342716
Feb 2023264
Mar 202331311
Apr 20231157
May 20234129
Jun 202331012
Jul 202301110
Aug 2023398
Sep 2023146
Oct 20234811
Nov 202341312
Dec 202342916
Jan 202441912
Feb 202461111
Mar 202421153
Apr 202446523
May 202402914
Jun 202441313
Jul 202451717
Aug 202481815
Sep 20240189
Oct 2024121913
Nov 20246129
Dec 20243166
Jan 202542116
Feb 202573813
Mar 202534334
Apr 202552666
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (10)
Journal of Nuclear Medicine
Vol. 58, Issue 10
October 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy
Milan Grkovski, Sally-Ann Emmas, Sean D. Carlin
Journal of Nuclear Medicine Oct 2017, 58 (10) 1567-1573; DOI: 10.2967/jnumed.117.190892

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy
Milan Grkovski, Sally-Ann Emmas, Sean D. Carlin
Journal of Nuclear Medicine Oct 2017, 58 (10) 1567-1573; DOI: 10.2967/jnumed.117.190892
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic 18F-FMISO PET for Head and Neck Cancer Radiotherapy
  • Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51
  • Google Scholar

More in this TOC Section

Oncology

  • Chimeric antigen receptor (CAR) T cells Imaging: Clinical Needs and Strategies for Success
  • Metastatic NUT Midline Carcinoma
  • Radionuclides used in Nuclear Therapeutic Medicine: a brief history, properties and main relevant studies of radionuclides with mass number less than 100
Show more Oncology

Translational

  • [99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
  • Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET
  • Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
Show more Translational

Similar Articles

Keywords

  • 18F-FMISO
  • hypoxia
  • perfusion
  • kinetic modeling
  • cediranib
  • antiangiogenesis
SNMMI

© 2025 SNMMI

Powered by HighWire